Zai Lab Limited ADR Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $443.8M+11.6% YoYTTM through 30 Jun 2026
Net Income -$188.2MTTM through 30 Jun 2026
Free Cash Flow -$139.6MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 58.5% |
| EBITDA Margin | -55.9% |
| Operating Margin | -49.9% |
| Net Margin | -42.4% |
Returns
-24.5%ROE
-15.0%ROA
Balance Sheet Health
Debt / Equity0.29x
Current Ratio2.45x
Net Debt-$485Mnet cash position
Cash & Equivalents$607.5M
Quality Metrics
Altman Z-Score0.39
Piotroski F-Score4 / 9
FCF Margin-31.5%
Earnings-Beat Rate50.0%
Multi-Year Trend
RevenueFY2025: $460.2M
Diluted EPS-$0.17TTMFY2025: $-0.16
Dividend
No dividend
Capital Allocation
R&D Spend$236.9M
Capex Intensity1.4%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.